Literature DB >> 35615243

Acute liver failure following paracetamol overdose.

Mohammed Asif Arshad1, Mansoor Nawaz Bangash1,2.   

Abstract

Acute liver failure is a rare syndrome comprising a coagulopathy of liver origin, jaundice and encephalopathy in a patient with no prior history of liver disease. Paracetamol overdose is the leading cause of acute liver failure in the United Kingdom and often presents with extrahepatic organ dysfunction requiring critical care. Presentation: We present the case of a patient with hyper acute liver failure secondary to paracetamol overdose. Management and discussion: Management focused on ensuring the correct diagnosis had been made, administering N-acetyl cysteine, fluid resuscitation and broad spectrum antimicrobials. Early intubation and transfer to a transplant centre were undertaken following development of hepatic encephalopathy. Neuroprotective measures and hypertonic saline were instituted to reduce the risk of intracranial hypertension. High dose haemofiltration was also started to help reduce ammonia levels. Aggressive critical care therapies with specialised input results in good outcomes for patients admitted with paracetamol induced hyper acute liver failure. Liver transplant is reserved for those patients unlikely to survive with medical treatment alone. © The Intensive Care Society 2021.

Entities:  

Keywords:  Paracetamol; acute liver failure; drug overdose; intensive care

Year:  2021        PMID: 35615243      PMCID: PMC9125438          DOI: 10.1177/17511437211007777

Source DB:  PubMed          Journal:  J Intensive Care Soc        ISSN: 1751-1437


  23 in total

1.  Lessons from look-back in acute liver failure? A single centre experience of 3300 patients.

Authors:  William Bernal; Anna Hyyrylainen; Amit Gera; Vinod K Audimoolam; Mark J W McPhail; Georg Auzinger; Mohammed Rela; Nigel Heaton; John G O'Grady; Julia Wendon; Roger Williams
Journal:  J Hepatol       Date:  2013-02-22       Impact factor: 25.083

2.  Outcomes and complications of intracranial pressure monitoring in acute liver failure: a retrospective cohort study.

Authors:  Constantine J Karvellas; Oren K Fix; Holly Battenhouse; Valerie Durkalski; Corron Sanders; William M Lee
Journal:  Crit Care Med       Date:  2014-05       Impact factor: 7.598

Review 3.  Acute liver failure: A curable disease by 2024?

Authors:  William Bernal; William M Lee; Julia Wendon; Fin Stolze Larsen; Roger Williams
Journal:  J Hepatol       Date:  2015-04       Impact factor: 25.083

4.  Functional loss of cerebral blood flow autoregulation in patients with fulminant hepatic failure.

Authors:  F S Larsen; E Ejlersen; B A Hansen; G M Knudsen; N Tygstrup; N H Secher
Journal:  J Hepatol       Date:  1995-08       Impact factor: 25.083

5.  Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration.

Authors:  J O Clemmesen; F S Larsen; J Kondrup; B A Hansen; P Ott
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

6.  Acute liver failure: redefining the syndromes.

Authors:  J G O'Grady; S W Schalm; R Williams
Journal:  Lancet       Date:  1993-07-31       Impact factor: 79.321

7.  Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure.

Authors:  Filipe S Cardoso; Michelle Gottfried; Shannan Tujios; Jody C Olson; Constantine J Karvellas
Journal:  Hepatology       Date:  2017-12-26       Impact factor: 17.425

8.  The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure.

Authors:  Nicholas Murphy; Georg Auzinger; William Bernel; Julia Wendon
Journal:  Hepatology       Date:  2004-02       Impact factor: 17.425

9.  Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study.

Authors:  Subrat Kumar Acharya; Vikram Bhatia; Vishnubhatla Sreenivas; Shankar Khanal; Subrat Kumar Panda
Journal:  Gastroenterology       Date:  2009-06       Impact factor: 22.682

10.  Ammonia clearance with haemofiltration in adults with liver disease.

Authors:  Andrew J Slack; Georg Auzinger; Chris Willars; Tracy Dew; Rebecca Musto; Daniel Corsilli; Roy Sherwood; Julia A Wendon; William Bernal
Journal:  Liver Int       Date:  2013-06-20       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.